Top R&D partnerships on biopharma therapeutics worldwide in 2020 by deal value

Published by
Matej Mikulic,
Sep 22, 2021
In 2020, six billion U.S. dollars were spent on the research and development of a biopharmaceutical through a partnership platform between Daiichi Sankyo and AstraZeneca. This statistic illustrates the elading research and development partnerships on biopharma therapeutics worldwide in 2020, by deal value and upfront payment.

Leading biopharma R&D partnerships and platforms on therapeutics worldwide in 2020, by deal value (in million U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

December 2020

Region

Worldwide

Survey time period

2020

Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you

Overview

6

Financials

4

Segments

3

Competitors

4

Costs

3

Further related statistics

15

Further Content: You might find this interesting as well

Statistics

Topics

SanofiGlobal pharmaceutical industryTop pharmaceutical drugsPfizerNovartis
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu